TR201911270T4 - Polimerik mirsen bileşimleri. - Google Patents

Polimerik mirsen bileşimleri. Download PDF

Info

Publication number
TR201911270T4
TR201911270T4 TR2019/11270T TR201911270T TR201911270T4 TR 201911270 T4 TR201911270 T4 TR 201911270T4 TR 2019/11270 T TR2019/11270 T TR 2019/11270T TR 201911270 T TR201911270 T TR 201911270T TR 201911270 T4 TR201911270 T4 TR 201911270T4
Authority
TR
Turkey
Prior art keywords
compositions
polymeric myrcene
polymeric
relates
myrcene
Prior art date
Application number
TR2019/11270T
Other languages
English (en)
Inventor
Hazan Zadik
Amselem Shimon
Original Assignee
Regenera Pharma Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regenera Pharma Ltd filed Critical Regenera Pharma Ltd
Publication of TR201911270T4 publication Critical patent/TR201911270T4/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/22—Anacardiaceae (Sumac family), e.g. smoketree, sumac or poison oak
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Microbiology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Vascular Medicine (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Oncology (AREA)
  • Pulmonology (AREA)
  • Obesity (AREA)
  • Child & Adolescent Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Communicable Diseases (AREA)

Abstract

Buluş, polimerik mirsen içeren bileşimler ve formülasyonlar ile ilgilidir. Özellikle buluş, bir hidrofobik taşıyıcı içinde polimerik mirsenin izole edilmiş bir fraksiyonunu içeren bileşimler ve aktif polimerin biyolojik aktivitesini muhafaza eden formülasyonlar ile ilgilidir.
TR2019/11270T 2009-03-04 2010-03-04 Polimerik mirsen bileşimleri. TR201911270T4 (tr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US15721609P 2009-03-04 2009-03-04

Publications (1)

Publication Number Publication Date
TR201911270T4 true TR201911270T4 (tr) 2019-08-21

Family

ID=42536397

Family Applications (1)

Application Number Title Priority Date Filing Date
TR2019/11270T TR201911270T4 (tr) 2009-03-04 2010-03-04 Polimerik mirsen bileşimleri.

Country Status (15)

Country Link
US (4) US8722105B2 (tr)
EP (2) EP3578191A1 (tr)
CN (2) CN105147759A (tr)
AU (1) AU2010220057C1 (tr)
BR (1) BRPI1013222B8 (tr)
CA (1) CA2754565C (tr)
DK (1) DK2403512T3 (tr)
EA (2) EA201492273A1 (tr)
ES (1) ES2739033T3 (tr)
HK (1) HK1218710A1 (tr)
HU (1) HUE045444T2 (tr)
IL (2) IL214923A (tr)
PL (1) PL2403512T3 (tr)
TR (1) TR201911270T4 (tr)
WO (1) WO2010100651A2 (tr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3578191A1 (en) 2009-03-04 2019-12-11 Regenera Pharma Ltd. Compositions of polymeric myrcene
ES2617875T3 (es) 2009-03-04 2017-06-20 Regenera Pharma Ltd. Usos terapéuticos de masilla de goma
WO2011051945A1 (en) * 2009-10-28 2011-05-05 Regenera Pharma Ltd. Therapeutic uses of oligomeric and polymeric monoterpenes
BR122019022461B1 (pt) * 2010-09-07 2022-03-15 Regenera Pharma Ltd Processo para preparar uma fração ácida isolada de goma mástique
US8979797B2 (en) * 2010-12-16 2015-03-17 Ams Research Corporation High pressure delivery system and method for treating pelvic disorder using large molecule therapeutics
WO2013011511A1 (en) 2011-07-18 2013-01-24 Mor Research Applications Ltd. A device for adjusting the intraocular pressure
CN102526163A (zh) * 2011-12-27 2012-07-04 浙江景岳堂药业有限公司 一种用于风痛灵中乳香和没药的提取方法
US20150246087A1 (en) * 2012-06-11 2015-09-03 Regenera Pharma Ltd. Extracts and therapeutic uses thereof
US10053603B2 (en) 2014-04-02 2018-08-21 Kraton Polymers U.S. Llc Block copolymers containing a copolymer myrcene block
US9458362B2 (en) 2014-04-02 2016-10-04 Kraton Polymers U.S. Llc Adhesive compositions containing a block copolymer with polymyrcene
IL237621A0 (en) * 2015-03-08 2015-06-30 Regenera Pharma Ltd Use of isolated fractions of the gum goddess to treat optic neuropathy
CA2999820A1 (en) 2015-09-24 2017-03-30 Regenera Pharma Ltd. Compositions comprising triterpenoids
DK3352742T3 (da) 2015-09-24 2022-01-10 Regenera Pharma Ltd Præparater omfattende triterpenoider til behandling af Alzheimers sygdom og Parkinsons sygdom
US10548917B2 (en) * 2016-05-23 2020-02-04 Kaeco Group Inc. Supplement for the prevention and treatment of gastrointestinal distress in horses and other species
US11439676B2 (en) 2018-10-16 2022-09-13 Kaeco Group, Inc. Method for prevention or treating gastrointestinal distress in humans using mastic gum compositions
US11207333B2 (en) 2016-09-08 2021-12-28 Regenera Pharma Ltd. Compositions comprising triterpenoids and uses thereof for treating optic neuropathy
EP3509577A4 (en) * 2016-09-08 2020-04-08 Regenera Pharma Ltd. COMPOSITION WITH ACID EXTRACTS FROM RUBBER FITTING AND USES THEREOF FOR TREATING OPTICAL NEUROPATHY
IT201700016726A1 (it) * 2017-02-15 2018-08-15 Phytoitalia Srl Frazioni arricchite in terpeni esenti da politerpeni estratte dal mastice di chios, dispositivi cosmetici, nutraceutici e medici, e composizioni farmaceutiche che le contengono
WO2019170239A1 (en) 2018-03-08 2019-09-12 Phytoitalia Srl Terpene enriched fractions free from polyterpenes extracted from chios mastic gum and cosmetic, nutraceutical, medical devices and pharmaceutical compositions containing them
CN113056281B (zh) * 2018-11-01 2023-05-26 耶迪特普大学 用于治疗牛皮癣的药物及其生产方法

Family Cites Families (35)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4374957A (en) 1981-10-29 1983-02-22 Michigan Molecular Institute Triblock polymers of a monovinyl aromatic compound and myrcene
US4564718A (en) 1984-08-14 1986-01-14 The University Of Manchester Institute Of Science And Technology Functionally terminated polymers from terpene monomers and their applications
US4713243A (en) 1986-06-16 1987-12-15 Johnson & Johnson Products, Inc. Bioadhesive extruded film for intra-oral drug delivery and process
JPS63179908A (ja) * 1987-01-22 1988-07-23 Japan Synthetic Rubber Co Ltd ミルセン重合体およびその製造方法
DE3820218A1 (de) 1988-06-14 1989-12-28 Osama L M Dr Med Dr Rer N Omer Phytotherapeutikum zur behandlung von depressivem syndrom
US8178516B2 (en) 1992-06-30 2012-05-15 Sylvan Labs, LLC Compositions and method for treatment of chronic inflammatory diseases
US5506406A (en) 1993-05-17 1996-04-09 Atomic Energy Corporation Of South Africa Ltd. Method and apparatus for determining the concentration of a heavy element in a rock face
US5759569A (en) 1995-01-10 1998-06-02 The Procter & Gamble Company Biodegradable articles made from certain trans-polymers and blends thereof with other biodegradable components
US5714007A (en) 1995-06-06 1998-02-03 David Sarnoff Research Center, Inc. Apparatus for electrostatically depositing a medicament powder upon predefined regions of a substrate
GR950100243A (el) 1995-06-28 1997-02-28 �. �����- �. ����� �.�.�. Χρησιμοποιηση της φυσικης μαστιχας χιου η του εξαγομενου εξ'αυτης φυσικου μαστιχελαιου η συνθετικων παραγωγων του για την παρασεκυη οδοντοκρεμας, οδοντικου διαλυματος, αποσμητικου στοματος, αντιηλιακων, προιοντων μαλλιων, καθως και καλλυντικων προιοντων.
JPH10130254A (ja) * 1996-11-01 1998-05-19 Jumoku Seiri Kinousei Butsushitsu Gijutsu Kenkyu Kumiai ジヒドロクマリン系化合物およびエストロゲン作用剤
DE19646392A1 (de) 1996-11-11 1998-05-14 Lohmann Therapie Syst Lts Zubereitung zur Anwendung in der Mundhöhle mit einer an der Schleimhaut haftklebenden, Pharmazeutika oder Kosmetika zur dosierten Abgabe enthaltenden Schicht
GR1003541B (el) 1999-05-11 2001-03-07 Αντιμικροβιακη και αντιμυκητιακη δραση του εξαγομενου απο τα κλαδια, φυλλα και καρπο της μαστιχας χιου -pistacia lentiscus var chia-, μαστιχελαιου, για χρηση σε καλλυντικες, φαρμακευτικες και παραφαρμακευτικεσς εφαρμογες καθως και στην παραγωγη οδοντοτσι
GR1003550B (el) 1999-09-22 2001-03-13 Σταθερο παρασκευασμα ισοεξυλοναφθαζαρινων με πεντα- και τετρα-κυκλικα τριτερπενια, συστατικα φυτικων ελαιορητινων και κομμεων
US6623728B2 (en) 2000-06-30 2003-09-23 Unilever Home & Personal Care Usa Division Of Conopco, Inc. Cosmetic skin care compositions and containing gum mastic
US7056491B2 (en) 2000-11-08 2006-06-06 Wisconsin Alumni Research Foundation Monoterpenes and sesquiterpenes as chemotherapeutic and radiation sensitizers and immunomodulators
GR1003868B (el) * 2001-02-06 2002-04-19 Lavipharm S.A. Αξιολογηση των επουλωτικων, αντιοξειδωτικων και κυτταροστατικων ιδιοτητων της μαστιχας και των συστατικων της, και οι εφαρμογες τους
JP2004518707A (ja) 2001-02-13 2004-06-24 イサム・リサーチ・デベロツプメント・カンパニー・オブ・ザ・ヘブルー・ユニバーシテイ・オブ・エルサレム カロテノイドを充填されたリポソーム
US6534548B1 (en) 2001-10-02 2003-03-18 Kimberly-Clark Worldwide, Inc. Isoprenoid compositions for the inhibition of exoprotein production from gram positive bacteria
AU2003241345A1 (en) 2002-05-01 2003-11-17 Lavipharm S.A. Use of mastic and its components for the control of microbial infections
JP2004083443A (ja) 2002-08-23 2004-03-18 Hideji Watanabe マスティックを用いた歯周病予防・治療用組成物及び歯周病予防・治療方法
US7232872B2 (en) 2002-12-20 2007-06-19 Exxonmobil Chemical Patents Inc. Polymerization processes
ATE469923T1 (de) 2002-12-20 2010-06-15 Exxonmobil Chem Patents Inc Polymere mit neuen sequenzverteilungen
US20050074509A1 (en) 2003-10-02 2005-04-07 Data Medica Padova S.P.A. Cancer treatment using natural plant products or essential oils extracted from some pistacia species or components
CA2548430A1 (en) 2003-12-08 2005-06-16 Kenneth John Falk Plant materials extraction method
JP4831488B2 (ja) 2004-03-04 2011-12-07 独立行政法人理化学研究所 アイソタクチック３，４−イソプレン系重合体
WO2005112967A2 (en) * 2004-05-19 2005-12-01 Balfour Marketing Corp. Anticancer activity of chios mastic gum
JP2008505685A (ja) 2004-07-06 2008-02-28 トランスファーマ メディカル リミテッド 経皮免疫処置用送達システム
EP1781235B1 (en) 2004-07-23 2013-12-25 Wholesome Life Science Co., Ltd. Anti-allergy activities of zingiber zerumbet (l.) smith
EP2263663A1 (en) 2004-11-13 2010-12-22 Metaproteomics, LLC Compositions comprising curcuminoids and either alpha or beta acids for use in the treatment of diabetes
US20070036873A1 (en) 2005-07-27 2007-02-15 Shibnath Ghosal Method of treatment or management of stress
US20070148187A1 (en) 2005-12-27 2007-06-28 Intact Enterprises, Inc. Mastic gum composition for use as a dietary supplement in humans and animals
AR060847A1 (es) 2007-05-03 2008-07-16 Spannagel Lucia Antonia Formulacion a base de calendula, aloe y centella.
ES2617875T3 (es) 2009-03-04 2017-06-20 Regenera Pharma Ltd. Usos terapéuticos de masilla de goma
EP3578191A1 (en) 2009-03-04 2019-12-11 Regenera Pharma Ltd. Compositions of polymeric myrcene

Also Published As

Publication number Publication date
ES2739033T3 (es) 2020-01-28
US10307449B2 (en) 2019-06-04
US20120039992A1 (en) 2012-02-16
CN102413834B (zh) 2016-11-09
EP2403512A2 (en) 2012-01-11
DK2403512T3 (da) 2019-07-22
EP3578191A1 (en) 2019-12-11
BRPI1013222A2 (pt) 2017-09-26
AU2010220057C1 (en) 2015-10-29
CN102413834A (zh) 2012-04-11
AU2010220057A1 (en) 2011-10-13
EA021833B1 (ru) 2015-09-30
US10806763B2 (en) 2020-10-20
WO2010100651A3 (en) 2010-10-28
US20170252387A1 (en) 2017-09-07
US20190255132A1 (en) 2019-08-22
IL214923A0 (en) 2011-11-30
PL2403512T3 (pl) 2019-10-31
AU2010220057B2 (en) 2015-04-02
US20140294928A1 (en) 2014-10-02
EA201492273A1 (ru) 2015-04-30
BRPI1013222B8 (pt) 2021-05-25
WO2010100651A4 (en) 2010-12-23
EA201190170A1 (ru) 2013-01-30
WO2010100651A2 (en) 2010-09-10
EP2403512B1 (en) 2019-05-15
IL248056A0 (en) 2016-11-30
HK1218710A1 (zh) 2017-03-10
BRPI1013222B1 (pt) 2021-03-16
IL214923A (en) 2016-10-31
CA2754565C (en) 2020-12-29
HUE045444T2 (hu) 2019-12-30
US9655938B2 (en) 2017-05-23
CN105147759A (zh) 2015-12-16
IL248056B (en) 2019-07-31
CA2754565A1 (en) 2010-09-10
US8722105B2 (en) 2014-05-13

Similar Documents

Publication Publication Date Title
TR201911270T4 (tr) Polimerik mirsen bileşimleri.
EA201190168A1 (ru) Терапевтические применения фракций мастиковой смолы
GT201200276A (es) Combinaciones de compuestos activos
BR112013021509A2 (pt) composições para cuidado pessoal
BR112012018021A2 (pt) antídotos anticoagulantes.
FR2941231B1 (fr) Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
BRPI0720153A8 (pt) Composições e artigos que contêm uma matriz de polímero reticulada e um líquido ativo imobilizado assim como processos de utilização dos mesmos
PE20141821A1 (es) Composiciones herbicidas que contienen bentazon y el inhibidor als y el inhibidor accasa
WO2011034877A3 (en) Silicone deposition aid for personal care compositions
EA201390260A1 (ru) Композиция для ухода за волосами
GT200600121A (es) Novedosos derivados de triazolopirimidina
PH12014501369A1 (en) Oral care compositions
CY1109209T1 (el) Μητρες ανιονικης υδρογελης με ph-εξαρτωμενη τροποιημενη αποδεσμευση ως μεταφορεις φαρμακων
EA201170062A1 (ru) Композиция
BR112016006321A2 (pt) enzima engenheirada tendo atividade aceto acetil-coa hidrolase, micro-organismos compreendendo a mesma, e processos de uso da mesma
FR2941232B1 (fr) Nouveaux peptides, compositions les comprenant et utilisations cosmetiques et dermo-pharmaceutiques.
SE0801639L (sv) Antimikrobiell sammansättning
TR200909785A1 (tr) Aktif ajan olarak sefdinir içeren farmasötik kompozisyonlar.
MY161460A (en) Elastomeric dental floss
CL2008001280A1 (es) Composicion farmaceutica que comprende una sal de aminoacido n-halogenado; procedimiento de preparacion; y su uso como antimicrobiano.
WO2012084419A3 (de) Wirkstoffkombinationen aus glucosylglyceriden und einer oder mehreren gegen kopfschuppen wirksamen substanzen
RS54594B1 (en) FORMULATIONS FOR THE CONTROL OF OBESITY CONTAINING SACCHAROMICES BOULARDII AND SUPEROXIDE DISMUTASE
RU2009136584A (ru) Растительное антгельминтное средство
WO2013100585A3 (ko) 세복수초 추출물 또는 그 유효물질을 이용한 항암제 조성물
TR201109158A2 (tr) Eplerenon içeren kolay çözünebilen farmasötik kompozisyon.